Results demonstrated that overexpression of ACSS2 notably decreased EZH2 levels in breast cancer cells (Fig. 4, D and E), whereas ACSS2 knockdown resulted in a marked increase in EZH2 levels (Fig. 4F). Here, EZH2 is linked to breast carcinoma.